Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

17.37
-0.6600-3.66%
Post-market: 17.750.3800+2.19%16:20 EDT
Volume:2.77M
Turnover:48.29M
Market Cap:2.18B
PE:-10.88
High:18.36
Open:18.22
Low:17.02
Close:18.03
Loading ...
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities